Median toxic dose
The median toxic dose (TD50) is a pharmacological term used to describe the dose of a drug or other substance that produces a toxic effect in 50% of the population exposed to it. It is a critical parameter in toxicology and pharmacology for assessing the safety and potential risks associated with chemical substances.

Definition[edit]
The median toxic dose is a statistical measure that helps in understanding the toxicity of a substance. It is similar to the median lethal dose (LD50), which is the dose that causes death in 50% of the population. However, TD50 focuses on non-lethal toxic effects, which can include a wide range of adverse reactions depending on the substance and the organism exposed.
Importance in Pharmacology[edit]
In pharmacology, understanding the TD50 of a drug is essential for determining its therapeutic index, which is the ratio between the toxic dose and the effective dose (ED50). A high therapeutic index indicates a relatively safe drug, whereas a low therapeutic index suggests a narrow margin between effective and toxic doses.
Calculation[edit]
The TD50 is typically determined through animal testing and clinical trials. Researchers administer varying doses of a substance to a population and observe the incidence of toxic effects. The data is then analyzed to find the dose at which 50% of the subjects exhibit a predefined toxic response.
Applications[edit]
The concept of TD50 is applied in various fields, including:
- Drug development: To ensure the safety of new pharmaceuticals.
- Environmental health: To assess the risk of exposure to chemicals in the environment.
- Regulatory toxicology: To establish safety guidelines and permissible exposure limits.
Limitations[edit]
While the TD50 provides valuable information, it has limitations. It does not account for individual variability in response to a substance, nor does it consider chronic exposure effects. Additionally, ethical considerations limit the extent of human testing, often necessitating reliance on animal models.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian